GlassScriptPhysician profile
Daniel Austin Cecil
NPI 1841817905
$5,070.89
in general payments reported to CMS, 2019-2025
11 companies · $606 in 2025
The $606 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.98 · 2021: $472 · 2022: $2,976 · 2023: $516 · 2024: $483 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,539.66 | 2021-2025 | |
| Alcon Vision LLC | $693.87 | 2021-2025 | Precision 1, Dailies Total1, Acrysof Iq Vivity |
| Coopervision INC. | $520.92 | 2022-2024 | Myday Contact Lens |
| Abbvie INC. | $428.44 | 2022-2025 | Alphagan P, Lumigan |
| Sun Pharmaceutical Industries INC. | $243.05 | 2021-2024 | |
| Tarsus Pharmaceuticals, INC. | $134.46 | 2024 | Xdemvy |
| Bausch & Lomb Americas INC. | $125.00 | 2022 | |
| Dompe US, INC. | $124.99 | 2025 | Oxervate |
| Glaukos Corporation | $118.68 | 2021 | |
| Oyster Point Pharma, INC. | $99.04 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.78 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cecil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.